The M184V mutation in HIV-1 reverse transcriptase reduces the restoration of wild-type replication by attenuated viruses

被引:30
|
作者
Wei, X
Liang, C
Götte, M
Wainberg, MA
机构
[1] McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, McGill AIDS Ctr, Montreal, PQ H3T 1E2, Canada
[2] McGill Univ, Dept Expt Med, Montreal, PQ, Canada
[3] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada
关键词
HIV-1 reverse transcriptase; initiation; tRNA(Lys3); M184V;
D O I
10.1097/00002030-200212060-00003
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: To study the ability of HIV constructs containing the M184V substitution in reverse transcriptase (RT), which causes resistance to lamivudine, to evolve mutations that compensate for deletions within the HIV genome. Methods: Viruses containing deletions in non-coding regions of the viral genome were examined in tissue culture to see whether the additional presence of M184V delays the reestablishment of wild-type replication kinetics. Potential compensatory mutations were identified by sequencing, and site-directed mutagenesis was carried out to confirm the biological relevance of such substitutions. The rate of initiation of reverse transcription was measured using either recombinant wild-type RT or RT containing M184V. Results: M184V-containing viruses were unable to undergo compensatory mutagenesis to reestablish wild-type replication kinetics, whereas viruses that did not contain M184V were able to mutate extensively. This ability was demonstrated most extensively in viruses deleted of an 'A-rich loop', located upstream of the primer-binding site, which is involved in initiation of reverse transcription. The rate of such initiation was severely diminished in virus containing the RT enzyme carrying the M184V substitution. This inhibitory effect was significantly enhanced in a biochemical system that included both the M184V mutant enzyme and a viral DNA template that contained the deletion in the A-rich loop. Conclusions: These findings provide further biological and biochemical evidence that M184V-containing viruses are impaired in replication fitness. Viruses that had the A-rich-loop deleted were able to reestablish replication ability quickly in the wild-type RT, which provides further evidence for the plasticity of the HIV genome. (C) 2002 Lippincott Williams Wilkins.
引用
收藏
页码:2391 / 2398
页数:8
相关论文
共 50 条
  • [41] Mechanistic basis for reduced viral and enzymatic fitness of HIV-1 reverse transcriptase containing both K65R and M184V mutations
    Deval, J
    White, KL
    Miller, MD
    Parkin, NT
    Courcambeck, J
    Halfon, P
    Selmi, B
    Boretto, J
    Canard, B
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (01) : 509 - 516
  • [42] Effectiveness of 3TC in HIV clinical trials may be due in part to the M184V substitution in 3TC-resistant HIV-1 reverse transcriptase
    Wainberg, MA
    Hsu, M
    Gu, ZX
    Borkow, G
    Parniak, MA
    AIDS, 1996, 10 : S3 - S10
  • [43] The impact of the HIV reverse transcriptase M184V mutation in combination with single thymidine analogue mutations on nucleoside reverse transcriptase inhibitor resistance in clinical samples from a large patient database
    Ross, L
    Parkin, N
    Bates, M
    Fisher, R
    St Clair, M
    Tisdale, M
    Lanier, R
    ANTIVIRAL THERAPY, 2003, 8 (03) : U134 - U135
  • [44] Molecular Docking Studies of Marine Diterpenes as Inhibitors of Wild-Type and Mutants HIV-1 Reverse Transcriptase
    Miceli, Leonardo A.
    Teixeira, Valeria L.
    Castro, Helena C.
    Rodrigues, Carlos R.
    Mello, Juliana F. R.
    Albuquerque, Magaly G.
    Cabral, Lucio M.
    de Brito, Monique A.
    de Souza, Alessandra M. T.
    MARINE DRUGS, 2013, 11 (11): : 4127 - 4143
  • [45] Increased drug susceptibility of HIV-1 reverse transcriptase mutants containing M184V and zidovudine-associated mutations: analysis of enzyme processivity, chain-terminator removal and viral replication
    Naeger, LK
    Margot, NA
    Miller, MD
    ANTIVIRAL THERAPY, 2001, 6 (02) : 115 - 126
  • [46] A Role of Template Cleavage in Reduced Excision of Chain-Terminating Nucleotides by Human Immunodeficiency Virus Type 1 Reverse Transcriptase Containing the M184V Mutation
    Acosta-Hoyos, Antonio J.
    Matsuura, Suzanne E.
    Meyer, Peter R.
    Scott, Walter A.
    JOURNAL OF VIROLOGY, 2012, 86 (09) : 5122 - 5133
  • [47] Compensation by the E138K Mutation in HIV-1 Reverse Transcriptase for Deficits in Viral Replication Capacity and Enzyme Processivity Associated with the M184I/V Mutations
    Xu, Hong-Tao
    Asahchop, Eugene L.
    Oliveira, Maureen
    Quashie, Peter K.
    Quan, Yudong
    Brenner, Bluma G.
    Wainberg, Mark A.
    JOURNAL OF VIROLOGY, 2011, 85 (21) : 11300 - 11308
  • [48] HIV-1 reverse transcriptase gene 103K/N and 184M/V combinations in tandem
    Mohey, R
    Tolstrup, M
    Jorgensen, LB
    Moller, BK
    Black, FT
    Kjems, J
    Obel, N
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2006, 41 (02) : 160 - 167
  • [49] Significance of the L74V mutation in HIV-1 reverse transcriptase
    Goette, Matthias
    Wainberg, Mark A.
    FUTURE VIROLOGY, 2006, 1 (04) : 493 - 500